TickerLeague

Buyback Spend for Revvity (RVTY)

Buyback Spend for Revvity (RVTY): headline value $820.82M · YoY +122.1%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$820.82M

YoY change

+122.1%

5Y CAGR

+159.7%

Peak year (2025)

$820.82M

Latest annual

$820.82M

Buyback Spend history chart for Revvity (RVTY) from 1989 to 2025

Buyback Spend history table for Revvity (RVTY) from 1989 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$820.82M+122.1%
2024$369.58M-5.0%
2023$388.88M+382.3%
2022$80.64M+10.4%
2021$73.07M+952.3%
2020$6.94M+10.0%
2019$6.31M-89.0%
2018$57.45M+1398.3%
2017$3.83M-97.5%
2016$151.80M+98.6%
2015$76.44M+16.6%
2014$65.53M-48.6%
2013$127.40M+5955.0%
2012$2.10M-98.1%
2011$110.00M+51.2%
2010$72.77M+397.8%
2009$14.62M-80.6%
2008$75.51M-62.8%
2007$202.97M+6.8%
2006$190.12M+679.3%
2005$24.40M
2004$0
2003$0-100.0%
2002$5.92M+232.1%
2001$1.78M-83.2%
2000$10.59M+958.9%
1999$1.00M-97.6%
1998$41.20M+46.6%
1997$28.10M-8.8%
1996$30.80M-77.2%
1995$135.10M+607.3%
1994$19.10M-57.6%
1993$45.00M+57.3%
1992$28.60M+18.2%
1991$24.20M-56.6%
1990$55.70M+13.7%
1989$49.00M

Buyback Spend values are taken from Revvity's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

In 2025, Revvity (RVTY) buyback spend totalled $820.82M – surged 122.1% year-over-year.

Revvity buyback spend has recorded the values shown across consecutive periods, with a +159.7% compound annual growth rate over 2020–2025 (5 years).

$820.82M stands as the all-time-high annual buyback spend, posted in 2025, against a low of $0 during 2003.

Among 8 Healthcare peers, Revvity (RVTY) ranks 7th; the peer median for buyback spend is $2.75B.

Revvity Buyback Spend by Year

Revvity Buyback Spend 2025: $820.82M

Revvity buyback spend in 2025 was $820.82M, surged 122.1% from 2024. This figure represents the highest annual value in the available history.

Revvity Buyback Spend 2024: $369.58M

Revvity buyback spend in 2024 was $369.58M, edged down 5.0% below 2023.

Revvity Buyback Spend 2023: $388.88M

Revvity buyback spend in 2023 was $388.88M, surged 382.3% from 2022.

Revvity Buyback Spend 2022: $80.64M

Revvity buyback spend in 2022 was $80.64M, grew 10.4% from 2021.

Revvity Buyback Spend 2021: $73.07M

Revvity buyback spend in 2021 was $73.07M.

See more financial history for Revvity (RVTY).

Sector peers — Buyback Spend

Companies in the same sector as Revvity, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is Revvity's buyback spend?

Latest reported buyback spend for Revvity (RVTY) is $820.82M (period ending December 28, 2025).

How has Revvity buyback spend changed year-over-year?

Revvity (RVTY) buyback spend changed +122.1% year-over-year on the latest annual filing.

What is the long-term growth rate of Revvity buyback spend?

Revvity (RVTY) buyback spend compound annual growth rate is +159.7% over the most recent 5 years available.

When did Revvity buyback spend hit its highest annual value?

Revvity buyback spend reached its highest annual value of $820.82M in 2025.

What was Revvity buyback spend in 2024?

Revvity (RVTY) buyback spend in 2024 was $369.58M.

What was Revvity buyback spend in 2025?

Revvity (RVTY) buyback spend in 2025 was $820.82M.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.